Pages that link to "Q37333155"
Jump to navigation
Jump to search
The following pages link to Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria (Q37333155):
Displaying 50 items.
- A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy (Q17485688) (← links)
- Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data (Q26783646) (← links)
- Direct transfer of HRPII-magnetic bead complexes to malaria rapid diagnostic tests significantly improves test sensitivity (Q27304525) (← links)
- The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic review (Q28079877) (← links)
- Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine (Q28542034) (← links)
- Measuring Patient Adherence to Malaria Treatment: A Comparison of Results from Self-Report and a Customised Electronic Monitoring Device (Q28546804) (← links)
- Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria. (Q33635019) (← links)
- Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso (Q34034413) (← links)
- Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania (Q34058351) (← links)
- Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine (Q34221884) (← links)
- Malaria in pregnancy in the Asia-Pacific region (Q34242348) (← links)
- Malaria: an update on current chemotherapy (Q34433106) (← links)
- Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN) (Q34485984) (← links)
- Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis (Q34677891) (← links)
- Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges (Q34953705) (← links)
- Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women (Q34974794) (← links)
- Time-to-infection by Plasmodium falciparum is largely determined by random factors. (Q35030175) (← links)
- Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria (Q35191473) (← links)
- Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implications (Q35286119) (← links)
- Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria (Q35363704) (← links)
- The influence of nevirapine and efavirenz-based anti-retroviral therapy on the pharmacokinetics of lumefantrine and anti-malarial dose recommendation in HIV-malaria co-treatment (Q35583982) (← links)
- Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria (Q35598379) (← links)
- Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria (Q35867343) (← links)
- Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects. (Q36017416) (← links)
- Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border. (Q36075976) (← links)
- Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria (Q36080121) (← links)
- Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria (Q36088256) (← links)
- Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy (Q36364248) (← links)
- Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda (Q36411652) (← links)
- Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers (Q36438820) (← links)
- The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics (Q36468109) (← links)
- Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim(®)) in the treatment of uncomplicated malaria at public health facilities in four African countries (Q36508726) (← links)
- A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan (Q36552289) (← links)
- Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms (Q36584636) (← links)
- Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria. (Q36644765) (← links)
- Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women (Q36898678) (← links)
- Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients (Q37038270) (← links)
- Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda (Q37263818) (← links)
- Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda (Q37366055) (← links)
- Safety, pharmacokinetics and efficacy of artemisinins in pregnancy (Q37481908) (← links)
- Obstetric Pharmacokinetic Dosing Studies are Urgently Needed (Q37575742) (← links)
- Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy (Q37735182) (← links)
- Prevention and treatment of malaria in pregnancy (Q37809067) (← links)
- Pharmacokinetics of antimalarials in pregnancy: a systematic review. (Q37942645) (← links)
- Comparable lumefantrine oral bioavailability when co-administered with oil-fortified maize porridge or milk in healthy volunteers (Q38865815) (← links)
- Treatment regimens for pregnant women with falciparum malaria (Q38870452) (← links)
- Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial (Q38871673) (← links)
- Use of artemether-lumefantrine to treat malaria during pregnancy: what do we know and need to know? (Q42712939) (← links)
- Treating malaria in pregnant women: a pressing problem (Q42844432) (← links)
- Intermittent preventive therapy for malaria in pregnancy: is sulfadoxine-pyrimethamine the right drug? (Q43182467) (← links)